ABOUT SIAT
RESEARCH
NEWS
EDUCATION
CAREER
Home
中文
CAS
HOME
ABOUT SIAT
Profile
Message from the President
Institutional Leadership
Annual Report
RESEARCH
About SIAT Research
Research Units
Shenzhen Institute of Advanced Integration Technology, CAS & CUHK (SIAIT, CAS & CUHK)
Institute of Biomedical and Health Engineering (IBHE)
Institute of Advanced Computing and Digital Engineering (IACDE)
Institute of Biomedicine and Biotechnology (IBB)
Institute of Brain Cognition and Brain Disease (BCBDI)
Institute of Synthetic Biology（iSynBio）
Institute of Advanced Materials Science and Engineering (AMSE)
Institute of Technology for Carbon Neutrality (ITCN)
Institute of Scientific Instrumentation (INSCI)
NEWS
SIAT Research
SIAT Innovate
SIAT Faces
Connect with SIAT
EDUCATION
Overview
Programs
Supervisors
Campus Life
CAREER
One-stop Service For Expats
Overview
Entry & Exit Policy
Welcome Guide
Payment
Immigration
Language Course
Tax
Work at SIAT
Human Resource
Research
Laboratory
Finance
Technology Transfer
Industry Cooperation
Study at SIAT
Degree
Scholarship
Exam
Accommodation
Student Program
Discipline
Campus Service
Safety
Archives
Dining
ID card
Other
Collaboration
Overview
Ministry of Science and Technology of the People' Republic of China (MOST)
National Natural Science Foundation of China (NSFC)
guide
Chinese Academy of Science (CAS)
Department of Science and Technology of Guangdong Province (GDSTC)
Shenzhen Science and Technology Innovation Commission (SZSTI)
International Fund
Infrastructures
Industry and Enterprise
Introduction
Cooperation Programs
Close Form
EVENTS
Home
EVENTS
【20171107】Toward genome editing based preclinical therapy for genetic diseases
Nov 01, 2017
【Print】
File Download：
